4//SEC Filing
Meggs Jason M. 4
Accession 0001209191-21-045846
CIK 0001610950other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 5:08 PM ET
Size
17.4 KB
Accession
0001209191-21-045846
Insider Transaction Report
Form 4
Meggs Jason M.
Chief Financial Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2021-07-06$46.00/sh+620$28,520→ 61,321 total - Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
2021-07-06−40→ 0 totalExercise: $43.16Exp: 2025-07-29→ Class A Common Stock (40 underlying) - Exercise/Conversion
Class A Common Stock
2021-07-06$43.16/sh+40$1,726→ 60,741 total - Sale
Class A Common Stock
2021-07-06$90.00/sh−40$3,600→ 60,701 total - Sale
Class A Common Stock
2021-07-06$90.00/sh−620$55,800→ 60,701 total - Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
2021-07-06−620→ 0 totalExercise: $46.00Exp: 2026-11-01→ Class A Common Stock (620 underlying)
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
- [F2]The shares subject to this option vested in four approximately equal annual installments on November 1, 2017; November 1, 2018; November 1, 2019; and November 1, 2020.
- [F3]The shares subject to this option vested in four approximately equal annual installments on July 29, 2016; July 29, 2017; July 29, 2018; and July 29, 2019.
Issuer
Syneos Health, Inc.
CIK 0001610950
Entity typeother
Related Parties
1- filerCIK 0001660670
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 5:08 PM ET
- Size
- 17.4 KB